{"acquisitions":[],"changes":[{"companyHref":"/c/alloytx-com","date":"2026-09-30","documentUrl":"https://www.8vc.com/companies","domain":"alloytx.com","fact":"provenance:investor:8vc","name":"Alloy Therapeutics, Inc.","new":{"publisher":"8VC","status":"sourced","url":"https://www.8vc.com/companies"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"8VC","reason":null,"retrievedAt":"2026-09-30","slug":"alloytx-com","status":"sourced","url":"https://whoraisedwhat.com/c/alloytx-com"},{"companyHref":"/c/alloytx-com","date":"2026-09-25","documentUrl":null,"domain":"alloytx.com","fact":"latest round","name":"Alloy Therapeutics, Inc.","new":{"amountUsd":30020259,"date":"2026-03-31","lead":null,"type":null},"old":{"amountUsd":30020259,"date":"2026-03-31","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-06","slug":"alloytx-com","status":"attributed","url":"https://whoraisedwhat.com/c/alloytx-com"}],"country":"US","description":"Alloy Therapeutics offers integrated drug discovery across antibodies, bispecifics, TCR mimics, genetic medicines, and cell therapy. It serves biopharma partners outsourcing computational design plus wet-lab validation. Differentiator: AI/ML predictive design fused with hands-on experimental execution.","domain":"alloytx.com","employees":null,"founded":2017,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":["8vc"],"lat":42.376238,"lng":-71.235564,"location":"Waltham, MA","multiples":[],"name":"Alloy Therapeutics, Inc.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":30020259,"connectionsAmong":[],"currency":"USD","date":"2026-03-31","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"alloytx-com-2026-03-31-round","source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-06","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"alloytx-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-06","status":"attributed","url":null},{"fact":"existence","publisher":"alloytx.com","retrievedAt":"2026-05-06","status":"self-reported","url":"https://alloytx.com"},{"fact":"description","publisher":"alloytx.com","retrievedAt":"2026-05-06","status":"self-reported","url":"https://alloytx.com"},{"fact":"investor:8vc","publisher":"8VC","retrievedAt":"2026-09-30","status":"sourced","url":"https://www.8vc.com/companies"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"8VC\", \"role\": \"portfolio\", \"slug\": \"8vc\", \"sources\": [{\"publisher\": \"8VC\", \"retrievedAt\": \"2026-09-30\", \"status\": \"sourced\", \"url\": \"https://www.8vc.com/companies\"}]}","kind":"investor","sources":[{"publisher":"8VC","retrievedAt":"2026-09-30","status":"sourced","url":"https://www.8vc.com/companies"}],"text":"Alloy Therapeutics, Inc. was listed in 8VC's portfolio, recorded 2026-09-30."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"8VC","role":"portfolio","slug":"8vc","sources":[{"publisher":"8VC","retrievedAt":"2026-09-30","status":"sourced","url":"https://www.8vc.com/companies"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress","Typekit","Adobe Fonts","Metronet Profile Picture 2.6.3","Lucky Orange","Yoast SEO 27.4","Yoast SEO Premium 23.8","reCAPTCHA","Google Tag Manager","jQuery Migrate 3.4.1","Elementor 4.0.2"],"totalRaisedUsd":30020259,"traction":[],"updatedAt":"2026-05-06","valuations":[]}